Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapy
To evaluate the frequency and severity of irAEs in patients with pre-existing autoimmunity, including irAE-related morbidity and mortality, irAE-related management and resolution, and outcome of ICI rechallenge, to better understand the treatment options for this vulnerable patient population. We de...
Saved in:
Published in | Current cancer reports Vol. 5; no. 1; p. 168 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
20.02.2024
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!